Risk factor assessments can rule out the need for CT angiography for pulmonary embolism, according to a new study published in Radiology.
Risk factor assessments can rule out the need for CT angiography for pulmonary embolism, according to a new study published in Radiology.
CT angiograms were negative for pulmonary embolism (PE) in 90.2% of 2003 patients, according to researchers at the University of California, Irvine. Among the 197 patients positive for PE, 97.5% had one or more risk factors. The risk factors were age, gender, cancer, history of immbolization, excess estrogen rate, a history of venous thromboembolism, and disorders that cause blood to clot easily.
All risk factors except gender were considered statistically significant. Age of 65 years or older and immobilization were the most common risk factors in positive PE patients. Risk factor assessment had a sensitivity of 97.5% and a negative predictive value of 99% in all patients.
Of the patients negative for PE, 28.8% had no risk factors. Excluding age and gender brought that figure to 62%.
Results were published online June 15 (Epub ahead of print).
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.